Enhabit, Inc. $EHAB Shares Sold by Paradice Investment Management LLC

Paradice Investment Management LLC trimmed its stake in Enhabit, Inc. (NYSE:EHAB) by 5.4% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 1,643,889 shares of the company’s stock after selling 93,075 shares during the quarter. Enhabit makes up about 3.0% of Paradice Investment Management LLC’s investment portfolio, making the stock its 16th largest holding. Paradice Investment Management LLC owned about 3.25% of Enhabit worth $15,157,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of EHAB. Hennion & Walsh Asset Management Inc. acquired a new stake in shares of Enhabit in the 4th quarter worth about $142,000. SG Americas Securities LLC acquired a new position in Enhabit during the 4th quarter valued at about $180,000. Verition Fund Management LLC acquired a new position in Enhabit during the 3rd quarter valued at about $228,000. Mercer Global Advisors Inc. ADV bought a new position in Enhabit in the 3rd quarter worth about $95,000. Finally, Bank of America Corp DE increased its stake in shares of Enhabit by 73.3% in the third quarter. Bank of America Corp DE now owns 687,934 shares of the company’s stock valued at $5,510,000 after purchasing an additional 290,978 shares during the period.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on EHAB shares. Jefferies Financial Group cut Enhabit from a “buy” rating to a “hold” rating and lifted their price target for the company from $12.50 to $13.80 in a report on Monday, February 23rd. Weiss Ratings reissued a “sell (d-)” rating on shares of Enhabit in a report on Tuesday, April 14th. TD Cowen reaffirmed a “hold” rating and set a $13.80 target price (up from $12.00) on shares of Enhabit in a research note on Friday, March 6th. UBS Group reiterated a “neutral” rating and set a $13.80 price target (up from $12.00) on shares of Enhabit in a research report on Tuesday, February 24th. Finally, Deutsche Bank Aktiengesellschaft raised Enhabit to a “buy” rating in a research note on Tuesday, January 13th. Two investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $13.57.

Insider Activity at Enhabit

In related news, EVP Julie Diane Jolley sold 2,793 shares of the stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $13.63, for a total transaction of $38,068.59. Following the completion of the sale, the executive vice president directly owned 139,923 shares of the company’s stock, valued at $1,907,150.49. This represents a 1.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 3.40% of the stock is owned by insiders.

Enhabit Stock Up 0.0%

EHAB stock opened at $13.74 on Friday. The firm’s 50-day moving average is $13.42 and its two-hundred day moving average is $10.74. The company has a market capitalization of $703.64 million, a price-to-earnings ratio of -152.61 and a beta of 1.45. Enhabit, Inc. has a 52 week low of $6.47 and a 52 week high of $14.22. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.76.

Enhabit (NYSE:EHAB) last posted its quarterly earnings data on Thursday, March 5th. The company reported $0.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.14. Enhabit had a negative net margin of 0.43% and a positive return on equity of 4.71%. The business had revenue of $270.40 million during the quarter, compared to analysts’ expectations of $270.56 million. On average, analysts forecast that Enhabit, Inc. will post 0.54 earnings per share for the current fiscal year.

About Enhabit

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.